Evidence map›Paper›PMID 30552179›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.

Abbey B Holt, Eszter Kormann, Alessandro Gulberti, Monika Pötter-Nerger, Colin G McNamara, Hayriye Cagnan, Magdalena K Baaske, Simon Little, Johannes A Köppen, Carsten Buhmann and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Closing the loop in psychiatric deep brain stimulation: physiology, psychometrics, and plasticity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Advances in Deep Brain Stimulation: From Mechanisms to Applications.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Abbey B HoltMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.ORCID 0000-0002-9747-8654
Eszter KormannMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.ORCID 0000-0003-0667-7189
Alessandro GulbertiDepartments of Neurophysiology and Pathophysiology.ORCID 0000-0003-0538-5109
Monika Pötter-NergerNeurology, and.
Colin G McNamaraMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.ORCID 0000-0001-8266-9266
Hayriye CagnanMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.ORCID 0000-0002-1641-115X
Magdalena K BaaskeMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.ORCID 0000-0001-9128-5280
Simon LittleSobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1E 6BT, United Kingdom, and.
Johannes A KöppenNeurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Carsten BuhmannNeurology, and.ORCID 0000-0001-8540-3789
Manfred WestphalNeurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Christian GerloffNeurology, and.
Andreas K EngelDepartments of Neurophysiology and Pathophysiology.ORCID 0000-0003-4899-8466
Peter BrownMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.ORCID 0000-0002-5201-3044
Wolfgang HamelNeurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Christian K E MollDepartments of Neurophysiology and Pathophysiology, andrew.sharott@pharm.ox.ac.uk c.moll@uke.de.
Andrew SharottMRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom, andrew.sharott@pharm.ox.ac.uk c.moll@uke.de.ORCID 0000-0002-1594-3349
University of Oxford · GBNeurology, Inc · USUniversität Hamburg · DEInstitut de Neurophysiopathologie · FRJohn Radcliffe Hospital · GBGeophysical Survey · RUSobell House · GB

Funding

Medical Research Council MC_UU_12024/1Medical Research Council MR/M014762/1Medical Research Council MR/R020418/1Wellcome Trust 105804/Z/14/ZWellcome Trust 209120/Z/17/Z
6 · The paper itself

Abstract

Synchronized oscillations within and between brain areas facilitate normal processing, but are often amplified in disease. A prominent example is the abnormally sustained beta-frequency (∼20 Hz) oscillations recorded from the cortex and subthalamic nucleus of Parkinson's disease patients. Computational modeling suggests that the amplitude of such oscillations could be modulated by applying stimulation at a specific phase. Such a strategy would allow selective targeting of the oscillation, with relatively little effect on other activity parameters. Here, activity was recorded from 10 awake, parkinsonian patients (6 male, 4 female human subjects) undergoing functional neurosurgery. We demonstrate that stimulation arriving on a particular patient-specific phase of the beta oscillation over consecutive cycles could suppress the amplitude of this pathophysiological activity by up to 40%, while amplification effects were relatively weak. Suppressive effects were accompanied by a reduction in the rhythmic output of subthalamic nucleus (STN) neurons and synchronization with the mesial cortex. While stimulation could alter the spiking pattern of STN neurons, there was no net effect on firing rate, suggesting that reduced beta synchrony was a result of alterations to the relative timing of spiking activity, rather than an overall change in excitability. Together, these results identify a novel intrinsic property of cortico-basal ganglia synchrony that suggests the phase of ongoing neural oscillations could be a viable and effective control signal for the treatment of Parkinson's disease. This work has potential implications for other brain diseases with exaggerated neuronal synchronization and for probing the function of rhythmic activity in the healthy brain.

Indexed as

Beta RhythmAgedCerebral CortexDeep Brain StimulationElectric StimulationElectroencephalographyFemaleHumansMaleMiddle AgedNeuronsNeurosurgical ProceduresParkinson DiseaseSubthalamic Nucleusbeta oscillationsclinical neurophysiologydeep brain stimulationParkinson's diseasesubthalamic nucleussynchrony

Identifiers

PMID30552179
PMCPMC6363933
OpenAlexW2951277489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.